United Bank Biogen Inc. Transaction History

United Bank

$234 Million
Q4 2024

A detailed history of United Bank transactions in Biogen Inc. stock. As of the latest transaction made, United Bank holds 1,423 shares of BIIB stock, worth $195,420. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,423

Previous 3,636 60.86%

Holding current value

$195,420

Previous $704,000 69.18%

% of portfolio

0.09%

Previous 0.33%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$146.47 - $191.55 $324,138 - $423,900	-2,213 Reduced 60.86%	1,423 $217,000
Q3 2024 Nov 01, 2024	SELL	$189.07 - $236.8 $23,822 - $29,836	-126 Reduced 3.35%	3,636 $704,000
Q2 2024 Jul 23, 2024	BUY	$190.52 - $236.72 $55,060 - $68,412	289 Added 8.32%	3,762 $872,000
Q1 2024 May 10, 2024	BUY	$212.02 - $267.71 $109,402 - $138,138	516 Added 17.45%	3,473 $748,000
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $20,478 - $24,650	-92 Reduced 3.02%	2,957 $765,000
Q3 2023 Oct 27, 2023	BUY	$253.3 - $285.89 $146,154 - $164,958	577 Added 23.34%	3,049 $783,000
Q2 2023 Aug 07, 2023	BUY	$275.25 - $318.06 $93,860 - $108,458	341 Added 16.0%	2,472 $704,000
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $546,729 - $622,976	2,131 New	2,131 $592,000
Q1 2020 May 08, 2020	SELL	$268.85 - $341.04 $627,764 - $796,328	-2,335 Closed	0 $0
Q4 2019 Feb 03, 2020	SELL	$220.06 - $304.07 $105,408 - $145,649	-479 Reduced 17.02%	2,335 $693,000
Q3 2019 Nov 08, 2019	BUY	$217.44 - $243.88 $1,087 - $1,219	5 Added 0.18%	2,814 $655,000
Q2 2019 Jul 22, 2019	BUY	$219.29 - $241.72 $179,379 - $197,726	818 Added 41.08%	2,809 $657,000
Q1 2019 May 01, 2019	SELL	$216.71 - $338.96 $79,965 - $125,076	-369 Reduced 15.64%	1,991 $471,000
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $119,755 - $151,682	-430 Reduced 15.41%	2,360 $710,000
Q3 2018 Nov 05, 2018	SELL	$293.51 - $383.83 $100,673 - $131,653	-343 Reduced 10.95%	2,790 $986,000
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $105,325 - $125,526	409 Added 15.01%	3,133 $909,000
Q1 2018 May 07, 2018	SELL	$260.13 - $367.91 $79,599 - $112,580	-306 Reduced 10.1%	2,724 $746,000
Q4 2017 Feb 07, 2018	SELL	$307.64 - $344.58 $15,997 - $17,918	-52 Reduced 1.69%	3,030 $965,000
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $866,504 - $1.02 Million	3,082	3,082 $965,000

Others Institutions Holding BIIB

# of Institutions

996

Shares Held

130M

Call Options Held

1.57M

Put Options Held

2.25M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $19.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Bank, based on Form 13F filings with the SEC.

News

Stay updated on United Bank with notifications on news.

Account